share_log

PAVmed's Earnings: A Preview

PAVmed's Earnings: A Preview

pavmed的收益:預覽
Benzinga ·  11/13 00:03

PAVmed (NASDAQ:PAVM) is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here's a quick overview of what investors should know before the release.

pavmed(納斯達克:PAVM)正準備在2024年11月13日(週三)公佈季度業績。以下是發佈前投資者應該知道的內容概述。

Analysts are estimating that PAVmed will report an earnings per share (EPS) of $1.97.

分析師們預計PAVmed將報告每股收益(EPS)爲$1.97。

Investors in PAVmed are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

PAVmed的投資者正急切地等待公司的公告,希望聽到超過預期的消息以及下一季度的積極指引。

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

值得新投資者注意的是,股票價格往往受未來預期的影響,而不僅僅是過去的業績。

Earnings History Snapshot

收益歷史快照

During the last quarter, the company reported an EPS beat by $0.61, leading to a 7.5% drop in the share price on the subsequent day.

在上個季度,該公司報告每股收益超出0.61美元,導致股價在隨後一天下跌了7.5%。

Here's a look at PAVmed's past performance and the resulting price change:

讓我們回顧一下PAVmed的過去表現以及由此導致的價格變動:

Quarter Q2 2024 Q1 2024 Q4 2023 Q3 2023
EPS Estimate -1.45 -1.67 -1.89 -2.1
EPS Actual -0.84 -0.99 -1.33 -3.3
Price Change % -8.0% 16.0% 33.0% 0.0%
季度 2024年第二季度 Q1 2024 2023年第四季度 2023年第三季度
每股收益預估值 -1.45 -1.67 -1.89 -2.1
每股收益實際值 -0.84 -0.99 -1.33 -3.3
價格變更% -8.0% 16.0% 33.0% 0.0%
bigjpg

Stock Performance

股票表現

Shares of PAVmed were trading at $1.12 as of November 11. Over the last 52-week period, shares are down 57.76%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

pavmed股票11月11日的交易價格爲1.12美元。在過去52周內,股價下跌了57.76%。鑑於這些回報通常是負面的,長期股東可能會對接下來的業績發佈感到有些不滿。

To track all earnings releases for PAVmed visit their earnings calendar on our site.

要追蹤pavmed的所有業績發佈,請訪問我們網站上的業績日曆。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文是由Benzinga的自動內容引擎生成,並由編輯審核。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論